209 related articles for article (PubMed ID: 20683858)
1. Correction of mucopolysaccharidosis type IIIA somatic and central nervous system pathology by lentiviral-mediated gene transfer.
McIntyre C; Byers S; Anson DS
J Gene Med; 2010 Sep; 12(9):717-28. PubMed ID: 20683858
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA.
McIntyre C; Derrick Roberts AL; Ranieri E; Clements PR; Byers S; Anson DS
Mol Genet Metab; 2008 Apr; 93(4):411-8. PubMed ID: 18248829
[TBL] [Abstract][Full Text] [Related]
3. Correction of murine mucopolysaccharidosis type IIIA central nervous system pathology by intracerebroventricular lentiviral-mediated gene delivery.
McIntyre C; Derrick-Roberts AL; Byers S; Anson DS
J Gene Med; 2014; 16(11-12):374-87. PubMed ID: 25418946
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.
Crawley AC; Gliddon BL; Auclair D; Brodie SL; Hirte C; King BM; Fuller M; Hemsley KM; Hopwood JJ
Brain Res; 2006 Aug; 1104(1):1-17. PubMed ID: 16828069
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
Bielicki J; McIntyre C; Anson DS
Mol Genet Metab; 2010 Dec; 101(4):370-82. PubMed ID: 20864369
[TBL] [Abstract][Full Text] [Related]
6. Exocytosis is impaired in mucopolysaccharidosis IIIA mouse chromaffin cells.
Keating DJ; Winter MA; Hemsley KM; Mackenzie KD; Teo EH; Hopwood JJ; Brooks DA; Parkinson-Lawrence EJ
Neuroscience; 2012 Dec; 227():110-8. PubMed ID: 23022219
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA.
Roberts AL; Howarth GS; Liaw WC; Moretta S; Kritas S; Lymn KA; Yazbeck R; Tran C; Fletcher JM; Butler RN; Byers S
J Cell Physiol; 2009 May; 219(2):259-64. PubMed ID: 19170061
[TBL] [Abstract][Full Text] [Related]
8. Correction of mucopolysaccharidosis type IIIb fibroblasts by lentiviral vector-mediated gene transfer.
Villani GR; Follenzi A; Vanacore B; Di Domenico C; Naldini L; Di Natale P
Biochem J; 2002 Jun; 364(Pt 3):747-53. PubMed ID: 12049639
[TBL] [Abstract][Full Text] [Related]
9. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
[TBL] [Abstract][Full Text] [Related]
10. Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.
King B; Savas P; Fuller M; Hopwood J; Hemsley K
Mol Genet Metab; 2006 Feb; 87(2):107-12. PubMed ID: 16352454
[TBL] [Abstract][Full Text] [Related]
11. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.
King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM
J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA.
Savas PS; Hemsley KM; Hopwood JJ
Mol Genet Metab; 2004 Aug; 82(4):273-85. PubMed ID: 15308125
[TBL] [Abstract][Full Text] [Related]
13. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes.
Fraldi A; Hemsley K; Crawley A; Lombardi A; Lau A; Sutherland L; Auricchio A; Ballabio A; Hopwood JJ
Hum Mol Genet; 2007 Nov; 16(22):2693-702. PubMed ID: 17725987
[TBL] [Abstract][Full Text] [Related]
14. High and prolonged sulfamidase secretion by the liver of MPS-IIIA mice following hydrodynamic tail vein delivery of antibiotic-free pFAR4 plasmid vector.
Quiviger M; Arfi A; Mansard D; Delacotte L; Pastor M; Scherman D; Marie C
Gene Ther; 2014 Dec; 21(12):1001-7. PubMed ID: 25142140
[TBL] [Abstract][Full Text] [Related]
15. Retrovirally transduced bone marrow has a therapeutic effect on brain in the mouse model of mucopolysaccharidosis IIIB.
Zheng Y; Ryazantsev S; Ohmi K; Zhao HZ; Rozengurt N; Kohn DB; Neufeld EF
Mol Genet Metab; 2004 Aug; 82(4):286-95. PubMed ID: 15308126
[TBL] [Abstract][Full Text] [Related]
16. Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIA.
Roberts AL; Rees MH; Klebe S; Fletcher JM; Byers S
Mol Genet Metab; 2007; 92(1-2):115-21. PubMed ID: 17681480
[TBL] [Abstract][Full Text] [Related]
17. Helper-dependent canine adenovirus vector-mediated transgene expression in a neurodegenerative lysosomal storage disorder.
Lau AA; Rozaklis T; Ibanes S; Luck AJ; Beard H; Hassiotis S; Mazouni K; Hopwood JJ; Kremer EJ; Hemsley KM
Gene; 2012 Jan; 491(1):53-7. PubMed ID: 21963444
[TBL] [Abstract][Full Text] [Related]
18. Liver production of sulfamidase reverses peripheral and ameliorates CNS pathology in mucopolysaccharidosis IIIA mice.
Ruzo A; Garcia M; Ribera A; Villacampa P; Haurigot V; Marcó S; Ayuso E; Anguela XM; Roca C; Agudo J; Ramos D; Ruberte J; Bosch F
Mol Ther; 2012 Feb; 20(2):254-66. PubMed ID: 22008915
[TBL] [Abstract][Full Text] [Related]
19. Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer.
Ruzo A; Marcó S; García M; Villacampa P; Ribera A; Ayuso E; Maggioni L; Mingozzi F; Haurigot V; Bosch F
Hum Gene Ther; 2012 Dec; 23(12):1237-46. PubMed ID: 22909060
[TBL] [Abstract][Full Text] [Related]
20. Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice.
Hemsley KM; King B; Hopwood JJ
Mol Genet Metab; 2007 Mar; 90(3):313-28. PubMed ID: 17166757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
